Insider screener

Period: 12 months Plan: Scheduled (10b5-1) × + Add filter Clear all
Saved screens

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

23,187 decisions over 12 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

23,187 decisions over 12 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

23,187 decisions over 12 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

23,187 decisions over 12 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
23,187 decisions over 12 months Remove this filter
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
23,187 decisions over 12 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

23,187 decisions over 12 months
Stock
Insider
Type ?
Why it stands out
12 Feb 2026
Ishbia Mat President and CEO · indirect
Sold on a plan
$2.99M 632,874 at 4.73
26.1%
Planned (10b5-1)
12 Feb 2026
Dwight A Merriman Director · indirect
Sold on a plan 4×
$2.19M 6,000 at 365.45
1.2%
Planned (10b5-1)
12 Feb 2026
Rex D Geveden President and CEO
Sold on a plan 6×
$2.03M 10,000 at 203.26
5.3%
Planned (10b5-1)
12 Feb 2026
Keith D Taylor Chief Financial Officer
Sold on a plan
$1.91M 2,000 at 956.44
7.6%
Planned (10b5-1)
12 Feb 2026
Campbell Rogers Chief Medical Officer
Sold on a plan
$1.60M 65,153 at 24.49
46.1%
Planned (10b5-1)
12 Feb 2026
Edith Morgan Flatley EVP - Global CMO
Sold on a plan
$1.55M 4,692 at 331.00
43.1%
Planned (10b5-1)
12 Feb 2026
Bought on a plan 2×
$1.44M 20,000 at 71.99
0.0%
Bought on a plan
12 Feb 2026
Matthew J. Zimpfer General Counsel
Sold on a plan
$1.33M 30,970 at 42.93
9.1%
Planned (10b5-1)
12 Feb 2026
Jason Kaiser Group President
Sold on a plan
$1.31M 1,690 at 776.70
16.3%
Planned (10b5-1)
12 Feb 2026
Pravin Dugel See Remarks
Sold on a plan
$1.13M 124,882 at 9.04
4.0%
Planned (10b5-1)
12 Feb 2026
Ahmed Farhan Moghal EVP, Chief Financial Officer · indirect
Sold on a plan
$1.11M 18,102 at 61.19
100%
Sold half or more
12 Feb 2026
Joseph D Mansueto Executive Chairman
Sold on a plan 3×
$1.07M 6,939 at 154.74
0.1%
Planned (10b5-1)
12 Feb 2026
Kelly Huller EVP, GC, Corporate Secretary
Sold on a plan
$876.70K 10,000 at 87.67
100%
Sold half or more
12 Feb 2026
Sherri R Luther Chief Financial Officer
Sold on a plan
$870.95K 4,000 at 217.74
5.2%
Planned (10b5-1)
12 Feb 2026
Lawson E Whiting President & CEO
Sold on a plan
$803.62K 25,915 at 31.01
78.7%
Sold half or more
12 Feb 2026
Yoav Landman Chief Technology Officer
Sold on a plan 3×
$797.79K 15,000 at 53.19
0.3%
Planned (10b5-1)
12 Feb 2026
Dhrupad Trivedi Chief Executive Officer
Sold on a plan
$685.33K 33,333 at 20.56
5.1%
Planned (10b5-1)
12 Feb 2026
Mac Armstrong CEO and Chairman · indirect
Sold on a plan 8×
$613.00K 5,000 at 122.60
1.4%
Planned (10b5-1)
12 Feb 2026
Brandi Galvin Morandi Chief People Officer
Sold on a plan 2×
$579.43K 600 at 965.72
6.3%
Planned (10b5-1)
12 Feb 2026
Robert Leinwand EVP: Chief Legal Officer
Sold on a plan
$565.02K 9,065 at 62.33
12.8%
Planned (10b5-1)
12 Feb 2026
Christopher Mutz Head of Rare Disease
Sold on a plan
$538.30K 7,032 at 76.55
7.1%
Planned (10b5-1)
12 Feb 2026
Pravin Desale SVP, R&D
Sold on a plan 9×
$498.53K 4,937 at 100.98
5.6%
Planned (10b5-1)
12 Feb 2026
Chad M Borton EVP, Pres Workforce Solutions
Sold on a plan
$485.45K 2,535 at 191.50
12.8%
Planned (10b5-1)
12 Feb 2026
Sold on a plan
$470.99K 90,000 at 5.23
29.5%
Planned (10b5-1)
12 Feb 2026
Kevin Patrick Danahy Chief Commercial Officer
Sold on a plan
$467.40K 20,000 at 23.37
31.6%
Planned (10b5-1)
12 Feb 2026
Scot B Jarvis Director
Sold on a plan
$442.00K 5,000 at 88.40
5.0%
Planned (10b5-1)
12 Feb 2026
Richard A Hayne CEO & Chairman of the Board
Sold on a plan 2×
$423.07K 5,992 at 70.61
0.0%
Planned (10b5-1)
12 Feb 2026
James S Mahan III Chief Executive Officer · indirect
Sold on a plan 2×
$401.10K 10,000 at 40.11
0.3%
Planned (10b5-1)
12 Feb 2026
Richard A Hayne CEO & Chairman of the Board · indirect also filed by Margaret Hayne
Sold on a plan 2×
$370.05K 5,241 at 70.61
0.3%
Planned (10b5-1)
12 Feb 2026
Adam Laponis Chief Financial Officer
Sold on a plan
$350.00K 7,000 at 50.00
5.1%
Planned (10b5-1)
12 Feb 2026
Daniel Bensen Chief Discovery Officer
Sold on a plan 2×
$262.96K 8,000 at 32.87
5.2%
Planned (10b5-1)
12 Feb 2026
Paula Tuffin General Counsel and CCO
Sold on a plan 2×
$229.88K 8,018 at 28.67
15.9%
Planned (10b5-1)
12 Feb 2026
Jeremy Wacksman Chief Executive Officer
Sold on a plan
$209.04K 4,729 at 44.20
3.5%
Planned (10b5-1)
12 Feb 2026
David Malcom Rodman Chief Medical Officer
Sold on a plan 2×
$184.08K 6,349 at 28.99
11.2%
Planned (10b5-1)
12 Feb 2026
Sold on a plan
$183.49K 900 at 203.88
12.6%
Planned (10b5-1)
12 Feb 2026
Patrick John Finn President and COO
Sold on a plan
$175.79K 3,500 at 50.23
1.1%
Planned (10b5-1)
12 Feb 2026
Dan Spaulding Chief People Officer
Sold on a plan
$172.39K 3,901 at 44.19
7.7%
Planned (10b5-1)
12 Feb 2026
Hunter C Smith Chief Financial Officer
Sold on a plan 4×
$156.38K 1,592 at 98.23
1.3%
Planned (10b5-1)
12 Feb 2026
Sold on a plan
$151.76K 1,500 at 101.17
3.1%
Planned (10b5-1)
12 Feb 2026
Dorchester Minerals Operating LP Entity Under Common Control
Bought on a plan
$125.40K 5,000 at 25.08
11.1%
Bought on a plan
12 Feb 2026
Barry D Quart Director
Sold on a plan
$121.05K 2,690 at 45.00
17.7%
Planned (10b5-1)
12 Feb 2026
Corey Neil Riley CIO & CCO
Sold on a plan
$95.94K 3,500 at 27.41
2.2%
Planned (10b5-1)
12 Feb 2026
Sanjay Nayak Chief Strategy Officer
Sold on a plan
$93.55K 10,348 at 9.04
3.0%
Planned (10b5-1)
12 Feb 2026
Bradley D. Owens General Counsel
Sold on a plan
$89.16K 2,017 at 44.20
5.3%
Planned (10b5-1)
12 Feb 2026
Nadia Waheed Chief Medical Officer
Sold on a plan
$71.08K 7,863 at 9.04
2.4%
Planned (10b5-1)
12 Feb 2026
Sold on a plan
$68.83K 1,012 at 68.01
3.7%
Planned (10b5-1)
12 Feb 2026
Sold on a plan
$50.51K 1,948 at 25.93
100%
Sold half or more
Showing 17,151–17,200 of 23,187. ← Newer Page 344 of 464 Older →